Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx Conference

Rhea-AI Summary

Cabaletta Bio, Inc. (Nasdaq: CABA) CEO to participate in fireside chat at Evercore ISI HealthCONx Conference

PHILADELPHIA, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced that Steven Nichtberger, M.D., Chief Executive Officer, will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, November 29, 2023 at 8:20 a.m. ET in Miami, FL.

A live webcast of the presentation will be available on the News and Events section of the Company’s website at www.cabalettabio.com. Replays will be available on the website for 30 days.

About Cabaletta Bio
Cabaletta Bio (Nasdaq: CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases. The CABA™ platform encompasses two strategies: the CARTA (chimeric antigen receptor T cells for autoimmunity) strategy, with CABA-201, a 4-1BB-containing fully human CD19-CAR T, as the lead product candidate being evaluated in systemic lupus erythematosus, myositis, systemic sclerosis and generalized myasthenia gravis, and the CAART (chimeric autoantibody receptor T cells) strategy, with multiple clinical-stage candidates, including DSG3-CAART for mucosal pemphigus vulgaris and MuSK-CAART for MuSK myasthenia gravis. The expanding CABA™ platform is designed to develop potentially curative therapies that offer deep and durable responses for patients with a broad range of autoimmune diseases. Cabaletta Bio’s headquarters and labs are located in Philadelphia, PA.

Contacts:

Anup Marda
Chief Financial Officer
investors@cabalettabio.com

William Gramig
Stern Investor Relations, Inc.
william.gramig@sternir.com

FAQ

What is the latest announcement from Cabaletta Bio, Inc. (Nasdaq: CABA)?

The CEO, Dr. Steven Nichtberger, will participate in a fireside chat at the 6th Annual Evercore ISI HealthCONx Conference on November 29, 2023.

Where will the fireside chat take place?

The fireside chat will take place at 8:20 a.m. ET in Miami, FL.

How can I watch the presentation live?

The live webcast will be available on the News and Events section of the company's website at www.cabalettabio.com.

Will there be replays available for the presentation?

Replays will be available on the website for 30 days after the presentation.